We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.50 (12.50%)
Open: 4.25
High: 4.25
Low: 4.25
Prev. Close: 4.25
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

18 Aug 2023 15:12

RNS Number : 8240J
Primorus Investments PLC
18 August 2023
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Interim Results for the six months ended 30 June 2023

 

Primorus Investments plc (AIM: PRIM) is pleased to announce its unaudited interim results for the six months ended 30 June 2023.

 

Overview

 

The last six months have been a difficult time for the capital markets with rising interest rates causing a general slowdown in the deployment of capital being invested. With greater uncertainties, investors are more cautious which has had a negative effect on the asset valuations for some of Primorus' investments. Despite this, we remain confident in the longer-term prospects of these investments.

 

Primorus has restructured the repayments due under its Convertible Loan Note with Bushveld Minerals Limited. At the date of this announcement, £307,000 has been repaid and the balance continues to accrue interest at 10% per annum.

 

Alteration Earth PLC, a special purpose acquisition company in which Primorus holds approximately 28% of the issued share capital, announced on 1 August 2023 its intention to acquire the entire issued share capital of Verdant Earth Resources Limited.

 

In addition, Primorus has exited several non-core holdings to ensure the Company remains in a healthy position to deliver the objectives set out within its investing policy.

 

Financial Results

 

The operating loss for the six months to 30 June 2023 was £512,000 (30 June 2022: £847,00 loss). The net loss after tax was £512,000 (30 June 2022: £847,000 loss).

 

Total assets, including cash, at 30 June 2023 amounted to £7.21 million (30 June 2022: £8.23 million).

 

Outlook

 

The Board remains confident that significant opportunities exist for the Company going forward. The Board is continually seeking new investment opportunities whilst also monitoring its existing investments.

 

The Board has screened several exciting opportunities within the period and looks forward to making further investments in the near term.

 

We look forward to updating shareholders as and when our existing investments mature, and new investments present themselves.

 

The Directors would like to take this opportunity to thank our shareholders and consultants for their continued support.

 

Rupert Labrum Chairman

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identied by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting the Company will be those that it anticipates.

 

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0)20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

 

+44 (0) 20 7213 0880

 

 

 

 

Unaudited Condensed Company Statement of Comprehensive Income

for the six months ended 30 June 2023

 

6 months to

6 months to

Year to

30 June

2023

30 June

2022

31 December

2022

Unaudited

Unaudited

Audited

Notes

£'000

£'000

£'000

Continuing operations

Revenue

Investment income

40

52

93

Realised (loss)/gain on disposal of financial investments

(538)

(300)

(288)

Unrealised gain/(loss) on market value movement of financial investments

314

(500)

(542)

Total (losses)/gains on financial investments

(184)

(748)

(737)

Share based payments

-

(63)

(121)

Operating costs

(328)

(36)

(280)

 

Impairment of financial investments

 

-

 

-

 

(375)

(Loss)/Profit before tax

(512)

(99)

(1,513)

Taxation

-

-

29

(Loss)/Profit for the period attributable to equity shareholders of the company

(512)

(847)

(1,484)

 

Other comprehensive income

-

-

-

Total Comprehensive Income for the year attributable to equity shareholders of the company

 

(512)

 

(847)

 

(1,484)

 

Profit/(Loss) per share:

Basic profit/(loss) per share (pence)

2

(0.366)

(0.605)

(1.061)

Diluted profit/(loss) per share (pence)

2

(0.366)

(0.605)

(1.061)

 

 

Unaudited Condensed Company Statement of Financial Position

as at 30 June 2023

 

30 June

2023

30 June

2022

31 December

2022

Unaudited

Unaudited

Audited

Note s

£'000

£'000

£'000

ASSETS

Non-current assets

Financial investments

5,279

7,742

5,444

5,279

7,742

5,444

 

Current assets

Investments

1,843

20

2,064

Trade and other receivables

49

39

34

Cash and cash equivalents

35

427

114

1,927

486

2,212

Total assets

7,206

8,228

7,656

 

EQUITY

Equity attributable to equity holders of the parent

Share capital

280

280

280

Share based payment reserve

-

76

-

Retained earnings

6,754

7,769

7.266

Total equity

7,034

8,125

7.546

LIABILITIES

Current liabilities

Trade and other payables

172

70

110

Corporation tax

-

33

-

Total liabilities

172

103

110

Total equity and liabilities

7,206

8,228

7,656

 

Unaudited Condensed Company Statement of Changes in Equity

for the six months ended 30 June 2023

 

 

Share capital

 

Share premium

Share based

payment reserve

 

Retained earnings

Total attributable

to owners of parent

 

£'000

£'000

£'000

£'000

£'000

Unaudited

 

 

 

 

 

Balance at 31 December 2021

280

-

13

8,616

8,909

 

Loss for the period

 

-

 

-

 

-

 

(1,484)

 

(1,484)

Total comprehensive income for the

period

 

-

 

-

 

-

 

(1,484)

 

(1,484)

Share based payment expense

 

-

-

121

-

121

Reclassification upon cancellation of share options

 

-

-

(134)

134

-

 

Balance at 31 December 2022

 

280

 

-

 

-

 

7,266

 

7,546

 

Loss for the period

 

-

 

-

 

-

 

(512)

 

(512)

Total comprehensive income for the period

 

-

 

-

 

-

 

(512)

 

(512)

Balance at 30 June 2023

280

-

-

6,754

7,034

 

 

 

Unaudited Condensed Company Statement of Cash Flows

for the six months ended 30 June 2023

 

 

6 months to

6 months to

Year

to

30-Jun-23

30-Jun-22

31-Dec-22

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Cash flows from operating activities

Operating Profit/(Loss)

(512)

(847)

(1,484)

Adjustments for:

(Profit)/Loss on disposal of financial investments

538

300

288

Fair value movement on listed investments

(314)

500

542

Impairment provision on unlisted investments

-

-

375

Decrease/(increase) in trade and other  receivables

(15)

(34)

-

Increase/(decrease) in trade and other payables

62

26

66

Foreign exchange loss/(gain)

166

(132)

(112)

Interest income on investments

(40)

(52)

(93)

Share based payment

-

63

121

Income tax (credit)

-

-

(29)

 

(115)

(176)

(326)

 

Income taxes paid

 

-

 

(4)

 

(36)

 

Net cash used in operating activities

(115)

(180)

(362)

Cash flows from investing activities

Disposal proceed from sale of financial investments

 

36

 

3,026

 

1,937

Payment for financial investments

-

(3,360)

(2,402)

Net cash from/(used in) investing activities

36

(334)

(465)

Net change in cash and cash equivalents

(79)

(514)

(827)

 

Cash and cash equivalents at beginning of period

 

114

 

941

 

941

Cash and cash equivalents at end of period

35

427

114

 

 

Notes to the condensed unaudited interim financial statements

 

1. General Information

 

The condensed interim financial information for the 6 months to 30 June 2023 does not constitute statutory accounts for the purposes of Section 434 of the Companies Act 2006 and has not been audited or reviewed. No statutory accounts for the period have been delivered to the Registrar of Companies.

 

The condensed interim financial information in respect of the year ended 31 December 2022 has been produced using extracts from the statutory accounts for that period. Consequently, this does not constitute the statutory information (as defined in section 434 of the Companies Act 2006) for the year ended 31 December 2022, which was audited. The statutory accounts for this period have been filed with the Registrar of Companies. The auditors' report was unqualified and did not contain a statement under Sections 498 (2) or 498 (3) of the Companies Act 2006.

 

The auditor's report was approved by the Directors on 15 June 2023 and is available on the Company's website at www.primorusinvestments.com.

 

2. Basis of preparation and accounting

 

The financial information has been prepared on the historical cost basis. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out in the Chairman's Statement. This statement also includes a summary of the Company's financial position and its cash flows.

 

The financial statements have been prepared in accordance with the Companies Act 2006 and UK-adopted international accounting standards (UK-adopted IAS) and related interpretations. As permitted, this does not include IAS 34 "Interim Financial Reporting". This condensed set of financial statements has been prepared applying the accounting policies that were applied in the preparation of the Company's published financial statements for the year ended 31st December 2022. As these interim financial statements do not include all of the information or disclosures required in the annual financial statements they should be read in conjunction with the Company's 2022 annual financial statements.

 

3. Earnings per share

 

Earnings per ordinary share has been calculated using the weighted average number of shares in issue during the period. The weighted average number of equity shares in issue was 139,830,968. IAS 33 requires presentation of diluted EPS when a company could be called upon to issue shares that would decrease earnings per share or increase the loss per share.

 

Six months

to

Six months

to

Year ended

30 June

2023

30 June

2022

31 December

2022

(Unaudited)

(Unaudited)

(Audited)

restated

(£'000)

(£'000)

(£'000)

Net profit/(loss) attributable to equity holders of

  the company

(512)

(847)

(1,484)

Weighted average number of shares

139,830,968

139,830,968

139,830,968

Weighted average number of diluted shares

139,830,968

139,830,968

139,830,968

Basic (loss)/profit per share (pence)

(0.366)

(0.605)

(1.061)

Diluted (loss)/profit per share (pence)

(0.366)

(0.605)

(1.061)

 

 

4. Events after the reporting date

 

There are no events after the end of the reporting date to disclose that have not already been the subject of an announcement by the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BSGDIGBBDGXI
Date   Source Headline
15th Apr 20247:00 amRNSInvestee Company Update – Engage Technology
25th Mar 20247:00 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSHolding(s) in Company
19th Mar 20242:45 pmRNSFurther re Dividend Declaration
11th Mar 20244:51 pmRNSDividend Declaration
8th Mar 202411:49 amRNSFurther Investment in Fresho Pty Ltd
27th Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSInvestee Company Update – Payapps Limited
2nd Feb 20243:26 pmRNSHolding(s) in Company
26th Jan 20247:00 amRNSInvestee Company Update – Payapps Limited
11th Oct 20239:59 amRNSDirector/PDMR Shareholding
28th Sep 20235:27 pmRNSDirector/PDMR Shareholding
19th Sep 20234:50 pmRNSHolding(s) in Company
15th Sep 20237:41 amRNSFurther re Investment in Interpac & Bushveld CLN
18th Aug 20233:12 pmRNSHalf-year Report
15th Aug 202312:06 pmRNSResult of AGM
2nd Aug 202310:25 amRNSAlteration Earth - Investment Update
20th Jul 20237:00 amRNSNotice of AGM
14th Jul 20234:00 pmRNSBushveld Convertible Loan Note Update
20th Jun 20237:00 amRNSConsent to Electronic Communication
16th Jun 20233:18 pmRNSFinal Results
16th Mar 20232:50 pmRNSDirector/PDMR Shareholding
19th Jan 20233:25 pmRNSHolding(s) in Company
19th Jan 20233:23 pmRNSDirector/PDMR Shareholding
8th Dec 20227:01 amRNSHolding(s) in Company
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
29th Nov 202211:05 amRNSSecond Price Monitoring Extn
29th Nov 202211:00 amRNSPrice Monitoring Extension
13th Sep 20223:50 pmRNSInvestment in Interpac Ltd
2nd Sep 20222:00 pmRNSHalf-year Report
1st Jul 20228:23 amRNSInvestment Update
30th Jun 202210:43 amRNSResult of AGM
10th Jun 20223:00 pmRNSFinal Results
6th Jun 202211:39 amRNSUpdate on Alteration Earth PLC Investment
31st May 20223:58 pmRNSNotice of AGM
4th May 202212:33 pmRNSUpdate on Alteration Earth PLC Investment
5th Apr 20227:00 amRNSUpdate on Alteration Earth PLC Investment
30th Mar 20228:12 amRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSFurther re Investment in Mustang
17th Mar 20224:12 pmRNSFurther Investment in Rambler Metals & Mining PLC
16th Mar 20221:05 pmRNSCancellation of Share Options
8th Mar 202210:48 amRNSUpdate on Alteration Earth PLC Investment
28th Feb 20224:45 pmRNSFurther re Investment in Mustang
16th Feb 20227:00 amRNSGeneral Update & Clean Power Hydrogen Investment
3rd Feb 20227:00 amRNSInvestment in Rambler Metals & Mining PLC
31st Jan 202210:54 amRNSAlteration Earth Update
19th Jan 20228:01 amRNSFurther re Investment in Mustang
24th Dec 202110:11 amRNSAlteration Earth update
21st Dec 20217:00 amRNSUpdate on Mustang Energy Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.